| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23,853 |
16,769 |
$2.27M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12,186 |
12,144 |
$1.19M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,277 |
2,081 |
$67K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
681 |
614 |
$55K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
486 |
486 |
$49K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
464 |
365 |
$47K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
5,960 |
4,064 |
$41K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
391 |
391 |
$40K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,614 |
1,482 |
$19K |
| S9083 |
Global fee urgent care centers |
203 |
161 |
$12K |
| 99050 |
|
577 |
560 |
$5K |
| 99051 |
|
494 |
476 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
65 |
61 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
109 |
101 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
54 |
52 |
$553.98 |
| 87428 |
|
14 |
14 |
$410.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
103 |
102 |
$333.75 |
| 87653 |
|
13 |
13 |
$231.48 |
| 81002 |
|
51 |
48 |
$95.08 |
| 36415 |
Collection of venous blood by venipuncture |
74 |
62 |
$5.28 |
| 94760 |
|
38 |
37 |
$0.70 |